Immuneering
IMRX
IMRX
50 hedge funds and large institutions have $88.1M invested in Immuneering in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+13
Holders Change %
+35.14%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
23
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$5.26M |
| 2 |
BlackRock
New York
|
$13.7M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$23.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
$1.38M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
$1.54M |
